Atlas Trials

Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer

Clinical trial NCT01551641 · UNKNOWN

Trial details

NCT number
NCT01551641
Sponsor
Changzhou No.2 People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2012-01-01
Primary completion
2016-03-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.